Pharmaceutical Opportunities : A three-step repositioning model for evaluating market options
Pharmaceutical industry is today struggling with its productivity as products keep failing after long and expensive development programs. The protability is further threatened by erce competition from cheaper product copies. As an attempt to increase the pipeline output, pharmaceutical companies hav...
Main Author: | SANDMAN, SARA |
---|---|
Format: | Others |
Language: | English |
Published: |
KTH, Industriell ekonomi och organisation (Inst.)
2016
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-199225 |
Similar Items
-
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
by: Daniele Parisi, et al.
Published: (2020-01-01) -
Changing Trends in Computational Drug Repositioning
by: Jaswanth K. Yella, et al.
Published: (2018-06-01) -
Drug Repositioning for Effective Prostate Cancer Treatment
by: Beste Turanli, et al.
Published: (2018-05-01) -
Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
by: Eric Wen Su, et al.
Published: (2017-03-01) -
Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
by: Henry Sung-Ching Wong, et al.
Published: (2019-11-01)